Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Famar buys Bayer plant in Quebec

by Rick Mullin
April 24, 2017 | A version of this story appeared in Volume 95, Issue 17

Famar Health Care Services, a Greek custom manufacturer with 11 facilities in the European Union, is establishing a foothold in North America with the acquisition of a Bayer plant in Pointe-Claire, Quebec. The facility makes liquid-, semisolid-, and solid-dosage-form drugs and employs about 150 people. Last year, Famar acquired a Roche dosage-form drug plant in Spain.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.